| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |